Literature DB >> 1880610

Dietary cholesterol and the origin of cholesterol in the brain of developing rats.

J Edmond1, R A Korsak, J W Morrow, G Torok-Both, D H Catlin.   

Abstract

Milk substitutes containing cholesterol at concentrations lower, equal to or greater than the concentrations found in natural rat milk were fed to artificially reared rat pups from 5 d until 15 or 16 d after birth. Pups reared by their mother served as controls. In one experiment, D7-cholesterol was fed in the milk at four different concentrations. The purpose of the study was to determine whether cholesterol in milk influenced growth and the sterol composition of brain over the period of its most rapid accumulation in this organ. We found that body and brain weights were not different, irrespective of the concentration of cholesterol in the milk substitutes. High concentrations of cholesterol in milk caused a significant increase in cholesterol in liver and plasma, whereas the concentration of cholesterol in brain was not different from the concentration in the brain of controls. The amounts of D7-cholesterol in lung and liver, and in plasma and RBC that pass the brain, were consistent with the concentration fed in the milk and approached 70% of the total content of cholesterol in these organs at the highest concentration fed. Brain, by contrast, contained very small amounts of D7-cholesterol, which could readily be attributed to D7-cholesterol associated with the vascular system of the blood-brain barrier. We found that the sterol composition of brain is not influenced by the concentration of cholesterol in milk and that cholesterol exogenous to brain, even in a hypercholesterolemic condition, does not gain entry to the brain. We conclude that the brain biosynthesizes de novo all the cholesterol it requires.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1880610     DOI: 10.1093/jn/121.9.1323

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  22 in total

Review 1.  Malformation syndromes caused by disorders of cholesterol synthesis.

Authors:  Forbes D Porter; Gail E Herman
Journal:  J Lipid Res       Date:  2010-10-07       Impact factor: 5.922

Review 2.  Origin of cholesterol in myelin.

Authors:  P Morell; H Jurevics
Journal:  Neurochem Res       Date:  1996-04       Impact factor: 3.996

3.  CHOLESTEROL AND NEURONAL SUSCEPTIBILITY TO BETA-AMYLOID TOXICITY.

Authors:  Alexandra M Nicholson; Adriana Ferreira
Journal:  Cogn Sci (Hauppauge)       Date:  2010-07-01

4.  In utero exposure to simvastatin reduces postnatal survival and permanently alters reproductive tract development in the Crl:CD(SD) male rat.

Authors:  Brandiese E J Beverly; Johnathan R Furr; Christy S Lambright; Vickie S Wilson; Barry S McIntyre; Paul M D Foster; Greg Travlos; L Earl Gray
Journal:  Toxicol Appl Pharmacol       Date:  2019-01-11       Impact factor: 4.219

Review 5.  Essential polyunsaturated fatty acids and the barrier to the brain: the components of a model for transport.

Authors:  J Edmond
Journal:  J Mol Neurosci       Date:  2001 Apr-Jun       Impact factor: 3.444

6.  Inactivation of liver X receptor beta leads to adult-onset motor neuron degeneration in male mice.

Authors:  Sandra Andersson; Nina Gustafsson; Margaret Warner; Jan-Ake Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-28       Impact factor: 11.205

Review 7.  Lipid status and fatty acid metabolism in phenylketonuria.

Authors:  M Giovannini; G Biasucci; C Agostoni; D Luotti; E Riva
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

Review 8.  Use of in vivo models to study the role of cholesterol in the etiology of Alzheimer's disease.

Authors:  Mark Burns; Karen Duff
Journal:  Neurochem Res       Date:  2003-07       Impact factor: 3.996

Review 9.  Early determinants of development: a lipid perspective.

Authors:  Susan E Carlson
Journal:  Am J Clin Nutr       Date:  2009-03-25       Impact factor: 7.045

10.  Brainstem concentrations of cholesterol are not influenced by genetic ablation of the low-density lipoprotein receptor.

Authors:  Ameer Y Taha; Chuck T Chen; Zhen Liu; John H Kim; Howard T J Mount; Richard P Bazinet
Journal:  Neurochem Res       Date:  2008-07-08       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.